Switch language or website
Switch Language
English
Español (ESP)
Português
Other countries and websites
AtlasPROfilax® is available around the world in many languages. Please select your region to switch to another website.
AtlasPROfilax® is available around the world in many languages. Please select your region to switch to another website.
Abstract: The aim of this study was to describe the effect of AtlasPROfilax® therapy on symptoms related to Temporomandibular Dysfunction (TMD), bruxism and on mandibular deviations during the opening and closing trajectory in a cohort of patients. Methodology: A descriptive observational follow-up study was carried out on 151 patients who attended the control 30 or 40 days after the therapy; in addition, a sub-sample of 71 patients was retaken and photographic analysis was carried out. Sociodemographic and clinical variables reported by the patient (at articular level pain, noise, jumping, blocking, limitation in opening and bruxism) and clinical variables taken from the photographic analysis (deviation from the midline in occlusion, opening and their difference) were taken. AtlasPROfilax® therapy reduced TMD-related symptoms and also reduced midline deviation in occlusion and aperture, but a Controlled Clinical Trial (CCT) with three and six months follow-up is required for further evaluation of the effectiveness of this therapeutic alternative.
"¡El dolor de cabeza se quitó del todo!"
Ortopedista Maxilar y Odontóloga narra su experiencia con AtlasPROfilax
Odontóloga nos cuenta su experiencia con AtlasPROfilax. "¡En este momento soy otra persona!"
La Dra. Victoria Gutiérrez habla sobre el Método AtlasPROfilax®
El Dr. Marcelo Garza habla sobre el método AtlasPROfilax®
La Dra. Lucy Calderón Zumárraga habla sobre el Método AtlasPROfilax®
(...)
